NanoString Technologies, a Seattle-based biotech company focused on developing cancer treatments, faced deepening losses this quarter as the company missed… Read More
Luke Timmerman, a respected biotechnology journalist known for his past work at The Seattle Times and Xconomy, today launched a new subscription-based biotech news… Read More
NanoString, a 12-year-old Seattle company whose tools help genetic researchers better analyze genes and molecules, is expanding its footprint in… Read More
Dendreon, a once-promising Seattle biotech company developing treatments for prostate cancer, today filed for Chapter 11 bankruptcy protection. It marks… Read More
Amgen dealt a blow to Seattle’s biotech industry last week with the announcement that it will be closing its large research-and-development campus… Read More
Seattle biotech company Stratos Genomics today announced a new partnership with Roche, a Switzerland-based biotech giant. Roche has made a strategic investment… Read More
AlCardiac Dimensions, a Kirkland-based company building heart-valve repair technology, today announced a $20 million round of financing led by M. H.… Read More
Seattle-based biotech upstart Kineta announced a new investment partnership with RLB Holdings, a Connecticut-based investment firm that partially owns the… Read More
